skip to main content

    Updated Visitor Guidelines

 

MENU

 

Learning to Predict Breast Cancer Metastasis

U-M Rogel Cancer Center and College of Engineering researchers found breast cancer cells that swallow up nearby stem cells, making it easier for them to invade other tissues and seed secondary tumors.

Pancreatic Survival Rates Improving

Since 2013, survival rates for pancreatic cancer have been slowly going up, making pancreatic cancer doctors hopeful that the next five years will see even bigger increases in survival rates -- as well as better care. University of Michigan researchers believe the immune system is the answer to overcoming pancreatic cancer.

Decoding the inner workings of cancer may help fight it

Cancer is not simply masses of cells but structured organs with multiple cell types that communicate with each other and interact with the body -- much like your lungs or liver.

Alternative to a Biopsy: Device Screens for Cancer in the Blood

A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a patient’s blood.

Keytruda given with chemotherapy resulted in 20 percent improved survival for advanced lung cancer patients

In the first large, randomized trial to look at immunotherapy as a first-line cancer treatment, researchers found that adding the immunotherapy drug pembrolizumab to chemotherapy for advanced lung cancer led to better tumor control and overall survival than chemotherapy followed by pembrolizumab.

Pembrolizumab and Chemotherapy Increase Survival for Advanced Lung Cancer Patients

The update on the KEYNOTE-189 trial provides nearly two years data on use of the immunotherapy drug pembrolizumab in combination with platinum-based chemotherapy as a first-line treatment for metastatic non-small cell lung cancer.

Pages